KIARA
LIVE

Serial Number

79445364

Owner

Bioplus International Co., Ltd.

Attorney

Janice Housey

Filing Date

Jan 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

KIARA Trademark

Serial Number: 79445364

KIARA is a trademark filed by Bioplus International Co., Ltd. on January 20, 2026. The trademark is classified under Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

Bioplus International Co., Ltd. (3 trademarks)

B-833, 27 Dunchon-daero 101beon-gil,

Entity Type: 99

Trademark Details

Filing Date

January 20, 2026

Registration Date

Not Registered

Published for Opposition

October 20, 2026

Goods & Services

Syringes for injections; medical devices for injecting pharmaceuticals; medical apparatus, namely, infusion and injection devices for administering medicines; medical device for nonsurgical cosmetic treatments, namely, cosmetic micro-needling devices to improve skin tone, texture and hydration; medical skin diagnostic apparatus for use in aesthetic treatment; electric facial aesthetic treatment apparatus, other than facial steamers; lasers for the cosmetic treatment of the face, skin, hair follicles; surgical implants and tissue grafts comprised of artificial materials for dermal repair and regeneration; massage apparatus for medical purposes; cannulae

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 14, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 14, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 14, 2026 TROA
REFUSAL PROCESSED BY IB
Jul 23, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 6, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jul 6, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 20, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 19, 2026 CNRT
ASSIGNED TO EXAMINER
May 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 12, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 12, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 12, 2026 REPR